Thymic involvement in recovery of immunity among HIV-infected adults on highly active antiretroviral therapy

Rafael de la Rosa and Manuel Leal*

Viral Hepatitis and AIDS Study Group, Department of Internal Medicine, Virgen del Rocío University Hospital, Avda. Manuel Siurot s/n., 41013 Seville, Spain

Keywords: thymus, HIV, HAART, recovery of immunity


    Introduction
 Top
 Introduction
 Evidence of thymic involvement...
 Thymic function-related markers
 Strategies in the setting...
 Conclusions
 References
 
Human immunodeficiency virus (HIV) infection is characterized by a decrease in both function and number of CD4 T cells, associated with viral replication and failure of homeostatic mechanisms involved in regeneration of immunity. The objective of highly active antiretroviral therapy (HAART) is to suppress HIV replication and achieve recovery of immunity in HIV-infected patients. This potent antiretroviral therapy allows successful suppression of HIV replication, with undetectable plasma HIV RNA levels being reached in the vast majority of patients on treatment. However, the degree of CD4 T cell repopulation induced by HAART is very heterogeneous between different patients,1 and depends on several host and virological factors.2

Previous studies and reviews have described broadly the characteristics of recovery of immunity in HIV-infected adults on HAART.1,2 Biphasic kinetics of CD4 cell repopulation following HAART have been proposed: an early increase phase associated with cellular redistribution from lymph nodes, and a later phase characterized by an increase in naive CD4 T cell counts associated with cellular de novo generation.

During the last few years, thymopoiesis has been suggested as one of the mechanisms of synthesis involved in T cell recovery following HAART. In the present review, we have summarized most of the recent and significant evidence that supports the involvement of the thymus in the recovery of immunity in HIV-infected adults on HAART.


    Evidence of thymic involvement in HIV-infected patients on HAART
 Top
 Introduction
 Evidence of thymic involvement...
 Thymic function-related markers
 Strategies in the setting...
 Conclusions
 References
 
The role of the thymus in the regeneration of naive T cells has been suggested previously in T cell depletion scenarios other than HIV disease, such as in intensive chemotherapy treatment received by patients diagnosed with cancer.3 In recent years, several studies have reported indirect evidence suggesting that thymic output might also be involved in recovery of immunity observed among HIV-infected patients on HAART.413

The use of the mediastinal imaging procedure has demonstrated the presence of thymic tissue in HIV-infected patients. By means of a single image, and representative mediastinal images, obtained by a thorax computerized tomography (CT) scan-based procedure, McCune et al.4 were the first to report the presence of abundant thymic tissue in HIV-infected adults. Later studies, using other imaging approaches, have also shown that increases in CD4 T cell counts induced by HAART were correlated with augmentation in thymic mass in both HIV-infected children5 and adults6 on HAART. Using a more reliable CT scan procedure, combined with the study of other molecular, cytometric and phenotypical thymic function-related markers, our group has observed recently that there is strong evidence for the involvement of thymic output in the recovery of immunity in antiretroviral-naive HIV-infected patients following HAART (Figure 1).7 Moreover, evidence of thymic function has also been reported among heavily-treated HIV-infected adults in whom virology has failed despite HAART.8



View larger version (14K):
[in this window]
[in a new window]
 
Figure 1. Response of thymic function-related markers to HAART. Mean ± S.E.M. (a) naive CD4 T cells/mm3, (b) TRECs/mm3, and (c) thymic volume (cm3) are shown for 15 HIV-1 infected subjects starting HAART (*Wilcoxon signed rank test, P < 0.05). Adapted from reference 7.

 
In the last few years, age has been strongly related to T cell repopulation in individuals receiving HAART.14 Thus, younger individuals have been reported to show higher CD4 T cell repopulation levels under HAART than older patients. Some authors have suggested that this response might be because younger patients have a more preserved thymic function and mass,14 which has been associated with immunological homeostasis produced mainly during childhood or young adulthood.15,16 Later studies, which analysed the influence of age on recovery of immunity among HIV-infected adults on HAART, have confirmed these findings.17,18


    Thymic function-related markers
 Top
 Introduction
 Evidence of thymic involvement...
 Thymic function-related markers
 Strategies in the setting...
 Conclusions
 References
 
Several procedures to assess thymic output in HIV-infected patients have been proposed. The markers used most frequently include thymic volume, measured by means of different thorax imaging procedures, quantification of T cell receptor excision circle (TREC)-bearing cells, and determination of naive T cell subsets. All these tools have advantages and limitations for the accurate determination of thymic function.

Thymic volume

Thymic size has been proposed as a useful and accessible way of assessing the impact of thymus on immunological recovery in HIV-infected individuals on HAART. Several thorax imaging approaches have been developed,410 the most widely used being the mediastinal CT scan.

Using this method, the presence of abundant thymic tissue in HIV-infected patients was demonstrated several years ago.4 Later, a relationship was identified between T cell repopulation and the increase in thymic size induced by HAART in both HIV-infected children5 and adults.6 However, this procedure, based on measuring the size of the thymus from a single representative CT image, had an important limitation: mediastinal fat could be mistaken for thymic tissue. Recently, we described an improved CT scan-based procedure, using detailed delineation of thymic shadows along several thin sections, which has allowed the accurate differentiation of thymic volume, minimizing the possible inclusion of mediastinal fat.7 Using this method, our group demonstrated that before implementation of HAART, thymic volume could be considered an independent predictor for an early successful immunological response induced by HAART in HIV-infected adults.9 Therefore, antiretroviral therapy-naive patients, who have a higher thymic volume at baseline, are more likely to be repopulated earlier with CD4 T cells than those patients who have lower thymic volume at that time (Figure 2). These results have been confirmed recently in a cohort of antiretroviral-naive HIV-infected children.10



View larger version (14K):
[in this window]
[in a new window]
 
Figure 2. Kaplan–Meier estimates of the probability of CD4 T cell repopulation among 37 untreated HIV-infected patients studied, depending on thymic volume (TV) at baseline. After 189 days (median of follow-up), eight out of 19 (42.5%) patients with TV ³3.22 cm3 had reached the required CD4 T cell repopulation, compared with only three out of 18 (16.6%) patients with TV < 3.22 cm3 ({chi}2 test, P = 0.003). Adapted from reference 9.

 
TREC-bearing cells

TRECs are products of T cell receptor gene rearrangements that are generated during lymphocyte maturation in the thymus.11,12 TRECs have been proposed as reliable thymic function-related markers because of their inherent characteristics: they are stable, they do not duplicate during the mitosis phase, and they become diluted rapidly during T cell proliferation.

TREC levels are reported to be increased in HIV-infected adults following HAART, suggesting that renewed thymic function occurs in this setting.11 However, several limitations associated with this thymic function-related marker have been proposed. The increase in TREC-bearing cells might also be the result of concomitant reduction in T cell proliferation and immune activation following HAART.12 Mechanisms of redistribution of TREC-bearing cells from lymph nodes to the peripheral blood have not been excluded completely.13 Despite these limitations, the association between the increase in TREC-bearing cells and thymic volume following HAART in an HIV-infected adult cohort, which has been described recently,7 and evidence from animal models,19 support the use of this molecular tool as a thymic function-related marker.

Naive T cell subsets

Recent evidence supports the view that immune reconstitution via the thymus is characterized by an increase in TREC+ naive T cells. Since this new T cell repertoire is polyclonal, it is able to mediate immune responses to new antigens. In contrast, reconstitution via peripheral expansion of pre-existing T cells may limit the T cell repertoire to pre-existing memory T cells that have a reduced capacity to respond to new antigens.20 Thus, T cell reconstitution via thymopoiesis is associated with the presence of naive-phenotype T cells and high TREC levels, whereas T cell regeneration via peripheral expansion is associated with memory-phenotype T cells and low TREC levels.5,21 According to this, the memory T cell count increase takes place within the first weeks or months after HAART.1,2 However, naive T cell subset repopulation tends to occur more slowly during the first year on potent antiretroviral therapy.1,2,11 Therefore, determining the phenotype of peripheral blood T cells can be helpful in evaluating the involvement of thymic function in the reconstitution of immunity in HIV-infected patients on HAART.

In the setting of HIV disease in children, naive T cell repopulation has been reported to occur within the first weeks on HAART,22,23 and to be correlated with the enlargement of thymic volume.5 In contrast, in the setting of adult HIV infection, the association between thymic function and recovery of naive T cell counts has been a controversial topic for several years. HIV-infected adults with abundant thymic tissue at baseline have been reported to achieve higher initial increases in naive T cell counts following HAART than patients whose thymic volume was less than abundant before starting potent therapy.7 However, a significant improvement in naive T cell counts has also been demonstrated among thymectomized HIV-infected patients undergoing HAART.24 Thus, this recovery of immunity has been attributed to mechanisms other than thymopoiesis, such as peripheral expansion25 and/or a rapid conversion into memory/ effector-phenotype T cells.26

In contrast, new evidence supports the use of naive T cell counts as reliable thymic function-related markers in adult patients. Franco et al.7 demonstrated that naive CD4 cell count increases, achieved in a population of antiretroviral-naive HIV-infected adults, were strongly correlated with increases in TREC-bearing cell counts following HAART. Moreover, repopulation of naive cell subsets is more likely to be higher in younger than older patients,18 regardless of their naive T cell count at the start of antiretroviral therapy. It has been suggested that thymus-dependent pathways are involved in this immune recovery.


    Strategies in the setting of thymus-dependent recovery of immunity
 Top
 Introduction
 Evidence of thymic involvement...
 Thymic function-related markers
 Strategies in the setting...
 Conclusions
 References
 
Several immunological strategies have been designed following knowledge of thymic involvement in the recovery of immunity in HIV-infected patients on HAART. These strategies should enhance CD4 T cell repopulation in adult HIV-infected patients who do not achieve significant immunological recovery despite HAART. Thus, the function and use of several endogenous cytokines related to thymic output, such as interleukin (IL)-2 and IL-7, have been analysed.

Combination therapies, including IL-2 plus HAART aimed at boosting T cell activity and maturation, have contributed significantly to the restoration of immune function in HIV-infected patients. HIV-infected adults on this regimen have been reported to achieve significantly higher increases in CD4 T cell numbers than patients treated only with HAART.27,28 This immunological approach might be a feasible therapeutic tool in virologically suppressed HIV-infected patients with CD4 cell counts lower than 200 cells/mm3 despite an appropriate HAART regimen. However, recent studies have suggested that the repopulation of the immune system, achieved by IL-2 treatment, may not be associated with a thymopoietic mechanism. This recovery of immunity is more likely to be the result of peripheral expansion of existing naive CD4 T cells, rather than an increase in thymic output.29,30

During the last few years, several lines of evidence have demonstrated the involvement of IL-7 levels in the restoration of homeostasis following T cell depletion scenarios,31 mainly through thymus-dependent pathways.32 Furthermore, a recent study has suggested that high levels of endogenous IL-7, produced in response to T cell depletion before HAART, may activate thymic rebound in adult HIV-infected patients on HAART.33 Unfortunately, exogenous administration of IL-7 should be approached with caution, since this cytokine has also been shown to increase naive T cell susceptibility to HIV infection.34

All these immunological approaches described herein, including growth hormone administration,35 have an important limitation. HIV-infected patients showing irreversible thymus damage will not be able to produce new T cells despite the exogenous administration of these substances. However, the application of these immunological findings in the setting of other immunodeficiency diseases might be indicated. Furthermore, thymic transplantation in HIV-infected adults with long-term viral suppression could be an alternative approach to explore in future studies.


    Conclusions
 Top
 Introduction
 Evidence of thymic involvement...
 Thymic function-related markers
 Strategies in the setting...
 Conclusions
 References
 
The combined use of thymic function-related markers shows that thymic tissue plays a role in CD4 T cell recovery reached under potent antiretroviral therapy in both HIV-infected children and adults. Evidence supporting this hypothesis is described above. However, short-term application of this immunological evidence cannot be considered at the present time. In the future, this insight may improve our understanding of the pathogenesis of HIV infection and enable the design of new approaches to HIV infection management.


    Acknowledgements
 
This work has been supported by research grants from Fondo Para la Investigación y Prevención del SIDA en España (FIPSE 2132/00 and FIPSE 12304/02, integrated by Ministerio de Sanidad y Consumo, Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme and Roche Laboratories). This work has also been partially supported by Red de Investigación en SIDA (RIS) by Ministerio de Sanidad y Consumo (Spain).


    Footnotes
 
* Corresponding author. Tel: +34-955-012-391; Fax: +34-955-012-390; E-mail: mleal{at}cica.es Back


    References
 Top
 Introduction
 Evidence of thymic involvement...
 Thymic function-related markers
 Strategies in the setting...
 Conclusions
 References
 
1 . Pakker, N. G., Nothermans, D. W., De Boer, R. J. et al. (1998). Biphasic kinetics of peripheral blood T-cells after triple combination therapy in HIV-infection: a composite of redistribution and proliferation. Nature Medicine 4, 208–14.[CrossRef][ISI][Medline]

2 . Lange, C. G. & Lederman, M. M. (2003). Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. Journal of Antimicrobial Chemotherapy 51, 1–4.[Abstract/Free Full Text]

3 . Mackall, C. L., Fleisher, T. A., Brown, M. R. et al. (1995). Age, thymopoiesis, and CD4 T-lymphocyte regeneration after intensive chemotherapy. New England Journal of Medicine 332, 143–9.[Abstract/Free Full Text]

4 . McCune, J. M., Loftus, R., Scmidt, D. K. et al. (1998). High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. Journal of Clinical Investigation 101, 2301–8.[Abstract/Free Full Text]

5 . Vigano, A., Vella, S., Saresella, M. et al. (2000). Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS 14, 251–61.[CrossRef][ISI][Medline]

6 . Smith, K. Y., Valdez, H., Landay, A. et al. (2000). Thymic size and lymphocyte restoration in patients with human immune deficiency virus infection alter 48 weeks of zidovudine, lamivudine and ritonavir therapy. Journal of Infectious Diseases 181, 141–7.[CrossRef][ISI][Medline]

7 . Franco, J. M., Rubio, A., Martínez-Moya, M. et al. (2002). T-cell repopulation and thymic volume in HIV-1-infected adult patients alter highly active antiretroviral therapy. Blood 99, 3702–6.[Abstract/Free Full Text]

8 . Delgado, J., Leal, M., Ruíz-Mateos, E. (2002). Evidence of thymic function in heavily antiretroviral-treated human immunodeficiency virus type 1-infected adults with long-term virologic treatment failure. Journal of Infectious Diseases 186, 410–14.[CrossRef][ISI][Medline]

9 . de la Rosa, R., Leal, M., Rubio, A. et al. (2002). Baseline thymic volume is a predictor for CD4 T-cell repopulation in adult HIV-infected patients under highly active antiretroviral therapy. Antiviral Therapy 7, 159–63.[ISI][Medline]

10 . Clerici, M., Saresella, M., Trabattoni, D. et al. (2002). Thymic volume predicts long-term immune reconstitution in HIV-infected children treated with highly active antiretroviral therapy. AIDS 16, 2219–21.[CrossRef][ISI][Medline]

11 . Zhang, L., Lewin, S. R., Markowitz, M. et al. (1999). Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. Journal of Experimental Medicine 190, 725–32.[Abstract/Free Full Text]

12 . Lempicki, R. A., Kovacs, J. A., Baseler, M. V. et al. (2000). Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T-cell turnover in HIV-infected patients. Proceedings of the National Academy of Sciences, USA 97, 13778–83.[Abstract/Free Full Text]

13 . Lewin, S. R., Ribeiro, R. M., Kaufmann, G. R. et al. (2002). Dynamics of T-cell and TCR excision circles differ after treatment of acute and chronic HIV infection. Journal of Immunology 15, 4657–66.

14 . Texeira, L., Valdez, H., McCune, J. et al. (2001). Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 15, 1749–56.[CrossRef][ISI][Medline]

15 . Steinmann, G. C., Klaus, B. & Muller-Hermenlink, H. K. (1985). The involution of aging human thymic epithelium is independent of puberty. A morphometric study. Scandinavian Journal of Immunology 22, 563–75.[ISI][Medline]

16 . Flores, K. G., Li, J., Sepowski, G. D. et al. (1999). Analysis of the human thymic perivascular space during aging. Journal of Clinical Investigation 104, 1031–9.[Abstract/Free Full Text]

17 . Viard, J. P., Mocroft, A., Chieasi, A. et al. (2001). Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: Evidence from the EuroSIDA study. Journal of Infectious Diseases 183, 1290–4.[CrossRef][ISI][Medline]

18 . Stuart, J. C., Hamann D., Borleffs, J. et al. (2002). Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age. AIDS 16, 2263–6.[CrossRef][ISI][Medline]

19 . Sodora, D. L., Milush, J. M., Ware, F. et al. (2002). Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alterations within the thymus. Journal of Virology 76, 9981–90.[Abstract/Free Full Text]

20 . Sempowski, G. D. & Haynes, B. F. (2002). Immune reconstitution in patients with HIV-infection. Annual Review of Medicine 53, 269–84.[CrossRef][ISI][Medline]

21 . Doueck, D. C., Vescio, R. A., Betts, M. R. et al. (2000). Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355, 1875–81.[CrossRef][ISI][Medline]

22 . Vigano, A., Dally, L., Bricalli, D. et al. (1999). Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection. Journal of Pediatrics 135, 675–82.[CrossRef]

23 . Franco, J. M., León-Leal, J. A., Leal, M. et al. (2000). CD4+ and CD8+ T lymphocyte regeneration alter anti-retroviral therapy in HIV-1-infected children and adult patients. Clinical and Experimental Immunology 119, 493–8.[CrossRef][ISI][Medline]

24 . Haynes, B., Hale, L. P., Weinhold, K. J. et al. (1999). Analysis of the adult thymus in reconstitution of T-lymphocytes in HIV-infection. Journal of Clinical Investigation 103, 453–60.[Abstract/Free Full Text]

25 . McLean, A. R. & Michie, C. A. (1995). In vivo estimates of division and death rates of human T lymphocytes. Proceedings of the National Academy of Sciences, USA 92, 3707–11.[Abstract/Free Full Text]

26 . Picker, L. J., Treer, J. R., Ferguson-Darnell, B. et al. (1993). Control of lymphocyte recirculation in man, I: differential regulation of the peripheral lymph node homing receptor L-selection on T-cells during the virgin to memory cell transition. Journal of Immunology 150, 1105–21.[Abstract/Free Full Text]

27 . Hengge, U., Goos, M., Esser, S. et al. (1998). Randomized controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral treatment (HAART) in HIV patients. AIDS 12, F225–34.

28 . Tambussi, G., Ghezzi, S., Nozza, S. et al. (2001). Efficacy of low-dose intermittent subcutaneous interleukin (IL)-2 in antiviral drug- experienced human immunodeficiency virus-infected persons with detectable virus load: a controlled study of 3 IL-2 regimens with antiviral drug therapy. Journal of Infectious Diseases 183, 1467–84.

29 . De Paoli, P., Bartolin, S. & Zanussi, A. (2001). Changes in thymic function in HIV-positive patients treated with highly active antiretroviral therapy and interleukin-2. Clinical Experimental Immunology 125, 440–6.[CrossRef][ISI][Medline]

30 . Natarajan, V., Lempicki, R. A., Sereti, I. et al. (2002). Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection. Proceedings of the National Academy of Sciences, USA 99, 10712–17.[Abstract/Free Full Text]

31 . Napolitano, N. A., Grant, R. M., Deeks, S. G. et al. (2001). Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nature Medicine 7, 73–9.[CrossRef][ISI][Medline]

32 . McKall, C. L., Fry, T. J., Bare, C. et al. (2001). IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97, 1491–7.[Abstract/Free Full Text]

33 . Ruiz-Mateos, E., de la Rosa, R., Franco, J. M. et al. (2003). Endogenous interleukin-7 is associated with increased thymic volume in adult HIV-infected patients under HAART. AIDS 17, 947–54.[CrossRef][ISI][Medline]

34 . Steffens, C., Managlia, E. Z., Landay, A. et al. (2002). Interleukin-7 treated naïve T-cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood 99, 3310–18.[Abstract/Free Full Text]

35 . Napolitano, L., Lo, J. C., Gotway, M. B. et al. (2002). Increased thymic mass and circulating naive CD4 T cells in HIV-1 infected adults treated with growth hormone. AIDS 16, 1103–11.[CrossRef][ISI][Medline]